Interim guidance from the IDSA recommends hydroxychloroquine/chloroquine in the context of a clinical trial and hydroxychloroquine/chloroquine plus azithromycin only’ in context of a clinical trial.

LEAVE A REPLY

Please enter your comment!
Please enter your name here